SALES HISTORY SINCE IPO 35,000,000 2019 19-20 20 in su summa - - PowerPoint PPT Presentation

▶
sales history since ipo
SMART_READER_LITE
LIVE PREVIEW

SALES HISTORY SINCE IPO 35,000,000 2019 19-20 20 in su summa - - PowerPoint PPT Presentation

Sep 14, 2022 169 likes •232 views

SALES HISTORY SINCE IPO 35,000,000 2019 19-20 20 in su summa mary 30,000,000 15 years as a public company 25,000,000 Acquisition of Tristel Italia 20,000,000 Launch of Cache surface portfolio 15,000,000

slide-1
SLIDE 1

SALES HISTORY – SINCE IPO

1

2019 19-20 20 in su summa mary

  • 15 years as a public company
  • Acquisition of Tristel Italia
  • Launch of Cache surface portfolio
  • Impact of Covid-19
  • 21% y-o-y sales growth in 2020
  • 17% CAGR since IPO

1 1

£- £5,000,000 £10,000,000 £15,000,000 £20,000,000 £25,000,000 £30,000,000 £35,000,000

slide-2
SLIDE 2

SALES HISTORY – BY GEOGRAPHY

2

2019 19-20 20 in su summa mary

  • UK sales growth 7%
  • International sales growth 32%
  • International sales benefit from

Tristel Italia contribution – acquired July 19

  • International sales now represent

60% of all revenue

2

£- £5,000,000 £10,000,000 £15,000,000 £20,000,000 £25,000,000 £30,000,000 £35,000,000 2015-16 2016-17 2017-18 2018-19 2019-20 UK sales International sales

slide-3
SLIDE 3

SALES HISTORY – BY PRODUCT CATEGORY

2019 19-20 20 in su summa mary

  • 12% Tristel medical device sales

growth

  • 139% Cache surface sales growth

Est stima mated d Covi

  • vid-19 impa

pact

  • £500k reduction in Tristel medical

device sales

  • £2m increase in Cache surface

sales

3

£- £5,000,000 £10,000,000 £15,000,000 £20,000,000 £25,000,000 £30,000,000 £35,000,000 2015-16 2016-17 2017-18 2018-19 2019-20 Other Cache Surfaces Tristel Medical Devices

slide-4
SLIDE 4

SECOND HALF SALES – COVID IMPACT

Secon

  • nd

d half lf 2019 19-20 20

  • March: Hospitals build their stock of

all infection prevention products.

  • April: Out-patient departments

close to all but Covid-19 patients. Reduced Tristel sales, but Cache sales hit an all time high.

  • May: Australasia, Asia & Europe
  • utpatient departments prepare to

re-open.

  • June: UK out-patient departments

prepare to re-open.

4

£- £500,000 £1,000,000 £1,500,000 £2,000,000 £2,500,000 £3,000,000 Jan-20 Feb-20 Mar-20 Apr-20 May-20 Jun-20 Tristel Medical Devices Cache Surfaces Other

slide-5
SLIDE 5

COVID IMPACT - PRODUCTION

Fe Februar ruary & Ma Marc rch 202 020

  • Senior management team

prepares a Covid-19 response plan April il & May May 202 020

  • 100% increase in bulk solution

manufacture

  • 100% increase in out-sourced

sachet filling output

  • 100% increase in production

personnel

  • The implementation of a fast

response plan allowed demand to be met.

5

0L 50,000L 100,000L 150,000L 200,000L 250,000L Jan-20 Feb-20 Mar-20 Apr-20 May-20 Jun-20

Bulk Solution Manufacture 2019-20